RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Mubadala Investment Co PJSC's Holding History (CIK: 0001704268)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 12,985,927 Value ($000) $63,371 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 12,985,927 Value ($000) $65,709 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 12,985,927 Value ($000) $68,696 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 12,985,927 Value ($000) $87,785 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 12,985,927 Value ($000) $85,577 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 12,985,927 Value ($000) $97,394 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 12,985,927 Value ($000) $129,470 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 12,985,927 Value ($000) $128,041 Avg Close $7.13 Range $4.97 - $11.17